Weijun Fu
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma | Phase 1 | 2022-09-01 |
| Unknown | A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-target Relapsed/Refractory Multiple Myeloma | Phase 1 | 2020-10-09 |